ISSN: 1879-4068

Journal Home

Journal Guideline

Journal of Geriatric Oncology Q2 Unclaimed

Elsevier Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Geriatric Oncology is a journal indexed in SJR in Oncology and Geriatrics and Gerontology with an H index of 48. It has an SJR impact factor of 1,025 and it has a best quartile of Q2. It has an SJR impact factor of 1,025.

Journal of Geriatric Oncology focuses its scope in these topics and keywords: patients, older, cancer, assessment, concurrent, elderly, gabnormal, added, patient, outcomes, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Geriatrics and Gerontology (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,025

SJR Impact factor

48

H Index

199

Total Docs (Last Year)

600

Total Docs (3 years)

7433

Total Refs

1659

Total Cites (3 years)

484

Citable Docs (3 years)

2.54

Cites/Doc (2 years)

37.35

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontiers in Oncology Q2
International Journal of Oncology Q2
Cancer Epidemiology Q2
Translational Lung Cancer Research Q2
Familial Cancer Q2

Compare this journals

Aims and Scope

Best articles by citations

Cetuximab plus platinum-based chemotherapy in elderly patients with recurrent or metastatic head and neck squamous cell carcinoma: A French experience from a single institution

Poor nutritional status is an independent factor of worse outcomes in the second group of Balducci score

Predictive value of each geriatric assessment domain for older patients with cancer: A systematic review

THE ROLE OF ADJUVANT THERAPY IN OLDER ADULTS WITH LUNG CANCER: CONTROVERSIES AND CHALLENGES

Modifiable factors affecting older patients' quality of life and physical function during cancer treatment

Increasing age and family history disproportionately increase risk of lung cancer

State of the art in the assessment and management of oncogeriatric surgical patients. Results from the SIOG surgical task force survey among ESSO and SSO members

TAXANES IN THE TREATMENT OF BREAST CANCER: HAVE WE BETTER DEFINED THEIR ROLE IN OLDER PATIENTS?

Prevalence of sarcopenia and its association with metabolic syndrome in Korean cancer survivors

CAREGIVERS OF OLDER ADULTS WITH CANCER - UNIQUE CHALLENGES AND FUNCTIONAL AND SOCIO-ECONOMIC IMPLICATIONS

Clinical aspects of the management of elderly women diagnosed with gynecologic malignancies: Treatment decisions and choices

Impact of urban/rural residency and poverty level on survivorship in older adults diagnosed with lung cancer in Georgia, USA

SHOW MORE ARTICLES

A comparison of younger and older patients' preferences for adjuvant chemotherapy and hormonal therapy in early breast cancer

Optimal management of localized rectal cancer in older patients

Treatment of acute promyelocytic leukemia in older patients: recommendations of an International Society of Geriatric Oncology (SIOG) task force

Surgical management of metastatic colon cancer: Analysis of the surveillance, epidemiology and end results (SEER) database

Evaluation of a pharmacist-led medication assessment used to identify prevalence and associations with potentially inappropriate medication (PIM) use among ambulatory senior adults with cancer

Pain reports and pain medication treatment in elderly patients with cancer: A retrospective cohort study of 311 patients

Continuing professional training program in skin cancer screening in elderly

Perceived self-management for older adults with cancer: Does multi-disciplinary teamwork make a difference?

NEW INTERVENTIONS FOR SARCOPENIA

Carboplatin and gemcitabine in patients with advanced and/or metastatic urothelial cancers: A phase II study

The association between cancer and falls in the elderly and the relationship between falls and sarcopenia in elderly individuals with cancer

Toxicities and outcome in elderly patients treated with targeted therapies for metastatic renal cell carcinoma